Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.

902.90
USD
-27.77
(-2.98%)
45.15EPS
16.19P/E
78.42BMarket Cap
Jan 29Next Earn

Regeneron Pharmaceuticals, Inc. Documents

Q4 FY2024 · Presentation

Regeneron Pharmaceuticals Inc - 43rd Annual J.P. Morgan Healthcare Conference 2025 - Conference Call Deck · 41 pages

Read Regeneron Pharmaceuticals, Inc.'s results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q4 FY2024 documents